Insider Cluster (2 insiders) ·Filed Aug 11, 2026

LLY

ELI LILLY & Co
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $8.3M total
Actionable Insight • Neutral

The $8.32M in insider sales is negligible relative to LLY's $1.14T market cap and follows a strong earnings beat — likely routine post-blackout-window diversification. No bearish signal. Monitor for any CEO/CFO selling or acceleration in insider sales volume above $50M in a 30-day window, which would be more material.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
LLY ▼ -7.47% at T+20d
NEUTRAL call ✗ call lost -7.47% · α vs SPY -6.42% · entry $1,215.02 → $1,124.21
Next anchor: T+60d in 15d
Latest observation: T+46 -7.40% FF3 residual α
Entry anchored
Aug 10, 07:46 PM ET
via 1-min bar
T+1d
+0.43%
call +0.43% · α +0.18%
$1,220.28
settled 2mo ago
T+5d
+0.88%
call +0.88% · α +1.29%
$1,225.73
settled 2mo ago
T+20d
-7.47%
call -7.47% · α -6.42%
$1,124.21
settled 6w ago
T+60d
—
call — · α —
—
in 15d

Price Chart

Loading chart...

Executive Summary

Two senior Eli Lilly executives (SVP Finance/CAO and EVP GC/Secretary) sold a combined $8.32M in open-market sales over a 7-day window, following the company's strong Q2 2026 earnings report (revenue up 48% YoY, EPS beat by 27%) and raised guidance. While the dollar amount is only ~0.0007% of LLY's $1.14T market cap — well below the 0.1% materiality threshold — the cluster occurs just 5-8 days after a bullish earnings release, and the cross-filing actuarial verdicts flag this as an amplified pattern (cluster-earnings-context + cluster-insider-trades). The sales are likely routine post-earnings blackout-window diversification by non-CEO C-suite officers, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$8.3M
Insiders
2

Key Facts

  • Total insider sales: $8.32M (0.0007% of $1.14T market cap)
  • Two C-suite officers sold: SVP Finance/CAO ($2.37M) and EVP GC/Secretary ($5.95M)
  • Sales occurred 5-8 days after Q2 2026 earnings beat (revenue +48% YoY, EPS +33%)
  • No CEO or CFO selling — both sellers are non-CEO senior officers
  • Cross-filing actuarial verdicts amplify this cluster pattern (cluster-earnings-context + cluster-insider-trades)

Financial Impact

$8.32M in insider sales, representing 0.0007% of market cap — economically trivial

Risk Factors

  • Insider sales could accelerate if Q3 2026 growth decelerates
  • No CEO/CFO selling yet, but if they begin selling, it would be a more significant signal

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
79% bullish (38 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-LLY-1786525873135
15 reports for LLY
Performance horizon
100% Hit rate 6 of 6 directional calls best @ T+60▲ +31.53%Apr 16, 2026
Filters
Rows
Reports for LLY — sortable, filterable
TypeNow
Sep 11, 2026
5w ago
Press Release
BULLISH ★ 5/10
$1,115.70 $1,179.27▲ +5.70%▲ +3.83%$1,257.03 (+12.67%)
Sep 8, 2026
5w ago
Court Ruling
NEUTRAL ★ 4/10
$1,123.91 $1,157.49▲ +2.99%▲ +1.02%$1,257.03 (+11.84%)
Aug 18, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$1,225.73 $1,137.82▼ −7.17%▼ −5.86%$1,257.03 (+2.55%)
Aug 11, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$1,215.02 $1,124.21▼ −7.47%▼ −6.42%$1,257.03 (+3.46%)
Aug 7, 2026
10w ago
Court Ruling
NEUTRAL ★ 3/10
$1,185.71 $1,149.36▼ −3.07%▼ −2.67%$1,257.03 (+6.01%)
Aug 5, 2026
10w ago
8-K
BULLISH ★ 8/10
$1,169.86 $1,160.08▼ −0.84%▼ −0.23%$1,257.03 (+7.45%)
Aug 4, 2026
10w ago
Court Ruling
BULLISH ★ 5/10
$1,115.68 $1,160.00▲ +3.97%▲ +5.21%$1,257.03 (+12.67%)
Jul 31, 2026
11w ago
Court Ruling
BEARISH ★ 7/10
$1,148.84 $1,174.61▼ −2.24%▲ +0.74%$1,257.03 (−9.42%)
Jul 30, 2026
11w ago
Court Ruling
BULLISH ★ 4/10
$1,154.97 $1,176.10▲ +1.83%▼ −2.14%$1,257.03 (+8.84%)
Jul 22, 2026
12w ago
Press Release
NEUTRAL ★ 2/10
$1,163.01 $1,280.34▲ +10.09%▲ +7.19%$1,257.03 (+8.08%)
Showing 10 of 15

US Market Status

Market Closed — Opens in 2h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 12, 2026